Nxera Pharma Licenses Japan and Select Asia-Pacific Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals

Vamorolone is approved and marketed as AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD) in the US, European Union, UK and ChinaNew ...

Santhera Licenses AGAMREE® (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Valued at up to USD 205 Million Plus Royalties

Ad hoc announcement pursuant to Art. 53 LRExclusive licensing agreement includes USD 40 million upfront comprising USD 30 million in cash and USD ...

Santhera Pharmaceuticals Holding AG: Santhera Licenses AGAMREE (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Valued at up to USD 205 ...

Ad hoc announcement pursuant to Art. 53 LR Exclusive licensing agreement includes USD 40 million upfront comprising USD 30 million in cash and USD 10 million equity investment at CHF 14.91 per share ...
Scientific Research Publishing

Regulation Mechanisms and Research Advances of Cochlear Immune Microenvironment in Sensorineural Hearing Loss ()

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

A tug-of-war explains a decades-old question about how bacteria swim

Scientists have uncovered a new explanation for how swimming bacteria change direction, providing fresh insight into one of ...

Scientists map development of pancreas transport channels that deliver digestive enzymes

Organs often have fluid-filled spaces called lumens, which are crucial for organ function and serve as transport and delivery ...
The Malaysian Reserve

RYBREVANT® (amivantamab-vmjw) longer-term results show promising and durable responses in difficult-to-treat colorectal cancer

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 monthsNotable ...
2 Minute Medicine

Infrapatellar Fat Pad Glucocorticoid Injection in Knee Osteoarthritis

Infrapatellar fat pad (IPFP) glucocorticoid injections do not significantly reduce pain or effusion volume compared to ...
Frontiers

Natural Products as Modulators of Neuronal and Glial Cellular Function in Cellular Neuropathology

Scientific and technological advances in the health field have contributed to improvements in the quality of life and an increase in life expectancy for the ...

Johnson & Johnson: RYBREVANT (amivantamab-vmjw) longer-term results show promising and durable responses in difficult-to-treat colorectal cancer

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable responses were ...